Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) — A comparative study

Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), 2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215

O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019

Palmerini, 2013, Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis, J Am Coll Cardiol, 62, 496, 10.1016/j.jacc.2013.05.022

Bangalore, 2013, Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient years of follow-up from randomized trials, Circ Cardiovasc Interv, 6, 378, 10.1161/CIRCINTERVENTIONS.113.000415

Serruys, 2012, From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?, Eur Heart J, 33, 16, 10.1093/eurheartj/ehr384

Finn, 2007, Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization, Circulation, 115, 2435, 10.1161/CIRCULATIONAHA.107.693739

Ormiston, 2012, First serial assessment at 6months and 2years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study, Circ Cardiovasc Interv, 5, 620, 10.1161/CIRCINTERVENTIONS.112.971549

Kajiya, 2013, Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI), EuroIntervention, 9, 501, 10.4244/EIJV9I4A80

Brugaletta, 2015, Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION study, JACC Cardiovasc Interv, 8, 189, 10.1016/j.jcin.2014.10.005

Sabate, 2015, Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial, Eur Heart J

Oberhauser, 2009, Design principles and performance of bioresorbable polymeric vascular scaffolds, EuroIntervention, 5, F15, 10.4244/EIJV5IFA3

Cutlip, 2007, Academic research consortium. Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313

Taylor, 2012, Third universal definition of myocardial infarction, Eur Heart J, 33, 2506

Nakatani, 2014, Early (before 6months), late (6–12months) and very late (after 12months) angiographic scaffold restenosis in the ABSORB Cohort B trial, EuroIntervention

Kochman, 2014, Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: optical coherence tomography evaluation and clinical outcomes, Cardiol J

Kočka, 2014, Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19', Eur Heart J, 35, 787, 10.1093/eurheartj/eht545

Diletti, 2014, Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study, Eur Heart J, 35, 777, 10.1093/eurheartj/eht546

Wiebe, 2014, Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold, Clin Res Cardiol, 103, 141, 10.1007/s00392-013-0630-x

Ielasi, 2014, Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry), EuroIntervention

Rzeszutko, 2014, Contemporary use of bioresorbable vascular scaffolds (BVS) in patients with stable angina and acute coronary syndromes. Polish National Registry, Kardiol Pol, 10.5603/KP.a2014.0147

Kraak, 2014, Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry, EuroIntervention